Gradual increase in thrombogenicity of juvenile platelets formed upon offset of prasugrel medication.


In patients with acute coronary syndrome, dual antiplatelet therapy with aspirin and a P2Y12 inhibitor like prasugrel is prescribed for one year. Here, we investigated how the hemostatic function of platelets recovers after discontinuation of prasugrel treatment. Therefore, 16 patients who suffered from ST-elevation myocardial infarction were investigated… (More)
DOI: 10.3324/haematol.2014.122457